Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc > Not sure if this is good or bad
View:
Post by rjc7 on Aug 15, 2024 9:01am

Not sure if this is good or bad

Of the 267,500 shares traded yesterday on the TSX 200,000 were ONE trade from seller house #7 to house #59.  Therefore only 67,500 were traded in total by smaller retailers on release of a great Q by a small biotech company that actually makes money. Hmmm....
Comment by Mbxwatcher on Aug 15, 2024 9:37am
A direct quote: " The question is, do capital markets in Canada recognize the value of publicly listed companies in a timely manner?  And if they do we will see our stock move up, if they dont, I think at some point our industry peers will say, this is stupid and will be bought out and it'll be another company that exits the public Canadian market" I think this remains the ...more  
Comment by wizzdumb on Aug 15, 2024 10:40am
For sure this is greatest risk, I'm surprised the guys behind Kinlytic haven't done this yet. Thankfully Cameron and other insiders hold a lot of shares so would drive a hard bargain. Best case is others wake up and see what a gem this is on core products alone, when you add in Kinlytic it's a no brainer at this point and I keep adding when I have capital to deploy. 
Comment by rjc7 on Aug 15, 2024 12:41pm
Well if the price was right I'd welcome it.  Been in it for 25 years, hold a ton of shares. Time to get out.
Comment by tasman99 on Aug 16, 2024 4:23am
YES RJC YOU AND ME BOTH 1998....iM;OLDER NEED THE CASH
Comment by wizzdumb on Aug 16, 2024 6:56am
Ask Cameron to do a block trade for you and exit if you need out. 
Comment by Method on Aug 16, 2024 7:35am
How much do you own?
Comment by Mbxwatcher on Aug 16, 2024 9:24am
2009 for me........I am a relative newbie here :)
Comment by Method on Aug 15, 2024 2:02pm
I think the Kinlytic royalty would have to be separated in any deal if it's pre-approval perhaps through a CVR with payouts based on revenue thresholds being met.    
Comment by wizzdumb on Aug 15, 2024 11:00am
....and is buying back its own shares.... Fond another one of those. 
Comment by Mbxwatcher on Aug 15, 2024 1:25pm
AT the levels we are at, i think Cameron and team would be hard pressed to get the value that we longtimers think it is worth. A 50% premium gets us to .50....I doubt there is many of us who have been here a while who would be very happy with that..  Anyway, i think they have solved most operational and financing risks, and the greatest impediment to the return we need is now a buyout.....
Comment by Method on Aug 15, 2024 1:29pm
It actually traded 360k across all markets. https://www.stockwatch.com/Quote/Detail?C:MBX&snapshot=SX
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities